The DOI matches its Crossref record; 23 of the 27 references it cites were found in a registry or an index.
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Open accessAbstract
Abstract The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematologic cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. Patients with nonmetastatic cancer experienced similar frequencies of severe conditions to those observed in patients without cancer. Patients who received surgery had higher risks of having severe events, whereas patients who underwent only radiotherapy did not demonstrate significant differences in severe events when compared with patients without cancer. These findings indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak. Significance: Because this is the first large cohort study on this topic, our report will provide much-needed information that will benefit patients with cancer globally. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients. This article is highlighted in the In This Issue feature, p. 747
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They are among the vulnerable groups because they are at higher risk of being infected and showing more severe symptoms and even death when infected.[13]”
From Psychological Distress of Breast Cancer Survivors During the COVID-19 Pandemic and Related Factors: A Controlled Study. (2023) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationCancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Self-citationPathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,040
Flagged first, then by citations
4 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,001
Jafari, M., Dastgheib, S. A., Ferdosian, F., Mirjalili, H., Aarafi, H., Noorishadkam, M., Mazaheri, M., & Neámatzadeh, H. (2021) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2021.09.020 · Cited by 10
Overheu, O., Lendowski, S., Quast, D. R., Marheinecke, C. S., Kourti, E., Lugnier, C., Andreica, I., Kiltz, U., Pfaender, S., & Reinacher‐Schick, A. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04099-7 · Cited by 10
Impact of Covid-19 on gastrointestinal cancer surgery: A National Survey
Parray, A. M., Chaudhari, V. A., BHANDARE, M. S., Madhabananda, K., Muduly, D. K., Sudhindran, S., Mathews, J., Pradeep, R., Thammineedi, S. R., Amal, K., et al. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-022-02675-6 · Cited by 10
Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis
Wang, L., Wang, Y., Cheng, X., Li, X., & Li, J. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101605 · Cited by 10
Self-citationMinkove, S. J., Sun, J., Li, Y., Cui, X., Cooper, D., Eichacker, P. Q., & Torabi‐Parizi, P. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2352 · Cited by 10
Escuissato, D. L. (2020) · Radiologia Brasileira · doi:10.1590/0100-3984.2020.53.4e1 · Cited by 10
Jassat, W., Cohen, C., Tempia, S., Masha, M., Goldstein, S., Kufa, T., Murangandi, P., Savulescu, D. M., Walaza, S., Bam, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3783089 · Cited by 11
Tharmalingam, H., Díez, P., Tsang, Y. M., Hawksley, A., Conibear, J., & Thiruthaneeswaran, N. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.06.002 · Cited by 9
Hathaway, C. A., Bloomer, A. M., Oswald, L. B., Siegel, E. M., Peoples, A. R., Ulrich, C. M., Penedo, F. J., Tworoger, S. S., & Gonzalez, B. D. (2022) · Health Psychology · doi:10.1037/hea0001172 · Cited by 9
Lau, M. C., Yang, Y., Goh, D. L. M., Cheung, C. C. L., Tan, B., Lim, J. C. T., Joseph, C. R., Wee, F. Y. T., Lee, J. N., Lim, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978760 · Cited by 9
Immunogenicity of COVID-19 vaccines in lung cancer patients
Provencio, M., Estival, A., Franco, F., López-Vivanco, G., Saigí, M., Arasanz, H., Díz, P., Carcereny, E., García, J., Aguado, C., et al. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2023.107323 · Cited by 9
Wu, W., Cheng, C., Yuan, D., Peng, L., & Li, L. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001766 · Cited by 9
Chen, C., Li, Y., Li, Y., Chen, Z., Shi, P., Xie, Y., & Qian, S. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01996-9 · Cited by 9
Self-citationBusiness Process as the Basis of the Process Approach in Enterprise Management
Nurlankyzy, N. A. (2019) · International Journal of Engineering and Management Research · doi:10.31033/ijemr.9.2.22 · Cited by 9
Bersanelli, M., Zielli, T., Perrone, F., Casartelli, C., Pratticò, F., Rapacchi, E., Camisa, R., Tognetto, M., Clemente, A., Giannarelli, D., et al. (2020) · Immunotherapy · doi:10.2217/imt-2020-0211 · Cited by 9
Hathout, L., Ennis, R. D., Mattes, M. D., Wagman, R. T., Grann, A., Jabbour, S. K., Singh, R., Yue, N. J., Haffty, B. G., & Vergalasova, I. (2020) · Advances in Radiation Oncology · doi:10.1016/j.adro.2020.10.013 · Cited by 9
Saponara, M., Pala, L., Conforti, F., Rubatto, M., Risi, I. D., Spagnolo, F., Guida, M., Bossi, P., Quaglino, P., & Queirolo, P. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920977002 · Cited by 9
Kanesvaran, R., Chia, C. S., Yap, S. P., Wang, M. L. C., Tham, C. K., Lim, S. T., Hwang, W. Y. K., & Kwek, J. W. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2020291 · Cited by 9
Cosimo, S. D., Tagliaferri, B., Generali, D., Giudici, F., Agustoni, F., Bernardo, A., Borgonovo, K., Farina, G., Luchena, G., Luciani, A., et al. (2021) · Cancers · doi:10.3390/cancers13061324 · Cited by 9
Deligiorgi, M. V., Siasos, G., Vakkas, L., & Trafalis, D. T. (2021) · Cancers · doi:10.3390/cancers13225785 · Cited by 9
Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis
Zyoud, S. H., Koni, A. A., Al‐Jabi, S. W., Amer, R. A., Shakhshir, M. H., Subu, R. A., Salameh, H. T., Odeh, R. Y., Musleh, S., Abushamma, F., et al. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i10.835 · Cited by 9
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease
Aleshina, O. A., Александровна, З. К., Vasileva, A. N., Dubov, S., Сергеевич, Д. В., Vorobyev, V. I., Сергеевич, Б. Л., Sukhareva, A. M., Gavrilova, L. V., Toropova, I. Y., et al. (2023) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2023.04.002 · Cited by 9
High Risk of Heart Tumors after COVID-19
Mitrofanova, L. B., Makarov, I. A., Гончарова, Э. А., Makarova, T., Starshinova, A. A., Kudlay, D. A., & Shlaykhto, E. V. (2023) · Life · doi:10.3390/life13102087 · Cited by 9
COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot
Singh, S. R. K., Thanikachalam, K., Jabbour-Aida, H., Poisson, L., & Khan, G. N. (2020) · Cancers · doi:10.3390/cancers12092377 · Cited by 9
Zambelli, A., Chiudinelli, L., Fotia, V., Negrini, G., Bosetti, T., Callegaro, A., Croce, A. D., Caremoli, E. R., Moro, C., Milesi, L., et al. (2020) · The Oncologist · doi:10.1002/onco.13654 · Cited by 9
Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature
Woźniak, K., Sachs, W., Boguradzki, P., Basak, G. W., & Stec, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.662211 · Cited by 9
Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint Inhibitors
Bui, A. N., Tyan, K., Giobbie‐Hurder, A., Klein, I. A., Manos, M. P., Zubiri, L., Reynolds, K. L., Grover, S., Weinhouse, G. L., Ott, P. A., et al. (2021) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-20-34 · Cited by 9
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic
Mukherji, R., & Marshall, J. L. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00888-3 · Cited by 9
Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results
Ruíz‐García, E., Peña‐Nieves, A., Alegría-Baños, J. A., Cornejo‐Juárez, P., Meneses-García, A., Rivera, S., Sánchez, J. J., Gerson-Cwilich, R., Gerson, D. S., Franco, H. M., et al. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211047755 · Cited by 9
Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan
Nomoto, H., Suzuki, S., Asai, Y., Hayakawa, K., Gatanaga, H., Terada, M., Suzuki, K., Ohtsu, H., Toyoda, A., & Ohmagari, N. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.10.021 · Cited by 9
Szabó, I. V., Simon, J., Nardocci, C., Kardos, A. S., Nagy, N., Abdelrahman, R.-H., Zsarnóczay, E., Fejér, B., Futácsi, B., Müller, V., et al. (2021) · Tomography · doi:10.3390/tomography7040058 · Cited by 9
Ruggeri, E., Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Berrios, J. R. G., Virtuoso, A., Marrucci, E., Mazzotta, M., Schirripa, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100350 · Cited by 8
Covid-19 Fobisi (Korkusu), Covid-19 Farkındalığı ve Genel Aidiyetleri Düzeyleri
Kurtuluş, E., & Düşünceli, B. (2021) · Üsküdar Üniversitesi Sosyal Bilimler Dergisi · doi:10.32739/uskudarsbd.7.13.96 · Cited by 11
Popescu, A., Craina, M. L., Pantea, Ș., Pîrvu, C. A., Radu, D., Marincu, I., Bratosin, F., Bogdan, I. G., Hosin, S., Cîtu, C., et al. (2022) · Healthcare · doi:10.3390/healthcare10040639 · Cited by 9
Fortin, J., Rivest‐Beauregard, M., Defer, C., Leblanc, M., Louis, L. A. T., Roy, C.-A., Lapierre, I., Brunet, A., Montreuil, M., & Marin, M. (2022) · Canadian Journal of Nursing Research · doi:10.1177/08445621221097520 · Cited by 9
Durkee-Shock, J. R., Lazarski, C. A., Jensen-Wachspress, M. A., Zhang, A., Son, A., Kankate, V. V., Field, N. E., Webber, K., Lang, H., Conway, S. R., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.04.013 · Cited by 9
Hajjaji, N., Lepoutre, K., Lakhdar, S., Bécourt, S., Béllier, C., Kaczmarek, E., Broyelle, A., Giscard, S., & Lartigau, E. F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.901426 · Cited by 9
Thompson, M. A., Hallmeyer, S., Fitzpatrick, V., Liao, Y., Mullane, M. P., Medlin, S. C., Copeland, K., & Weese, J. L. (2022) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1952 · Cited by 9
Koo, J., Auletta, J. J., Hartley, D., Huber, J. F., Jaglowski, S. M., Kapadia, M. A., Kusnier, K., Lehmann, L., Maakaron, J. E., Myers, K. C., et al. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.07.020 · Cited by 9
COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews
Sun, H., Bu, F., Li, L., Zhang, X., Yan, J., & Huang, T. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1072137 · Cited by 9
Real-World Evidence of Safety and Influence for Lung Cancer Surgery Under COVID-19 Pandemic in Japan
Kato, T., Katsuya, R., Okado, S., Sato, K., Noritake, O., Nakanishi, K., Noguchi, M., Kadomatsu, Y., Ueno, H., Ozeki, N., et al. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-1289 · Cited by 9
Liu, Z., Huang, H., Yu, Y., Jia, Y., Li, L., Shi, X., & Wang, F. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230510124716 · Cited by 9
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis
Angues, R. V., & Bustos, Y. P. (2023) · Cureus · doi:10.7759/cureus.50703 · Cited by 11
Akan, S., Ediz, C., Kızılkan, Y. E., Alçın, A., Tavukçu, H. H., & Yılmaz, Ö. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13752 · Cited by 9
COVID-19 and Its Impact on Upper Gastrointestinal (GI) Cancer Management
Fernando, S., Veli, M., Mohammadi, B., Millar, A., & Khan, K. H. (2021) · Cancers · doi:10.3390/cancers13030397 · Cited by 9
Respiratory Failure in a Child With Pulmonary Metastatic Osteosarcoma and COVID-19
Offenbacher, R., Fabish, L., Baker, A. C., Chou, A. J., & Loeb, D. M. (2020) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001897 · Cited by 8
Kaur, H., Thakur, J. S., Paika, R., & Advani, S. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.5.1333 · Cited by 8
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
Bisceglia, I., Gabrielli, D., Canale, M. L., Gallucci, G., Parrini, I., Turazza, F. M., Russo, G., Maurea, N., Quagliariello, V., Lestuzzi, C., et al. (2021) · European Heart Journal Supplements · doi:10.1093/eurheartj/suab067 · Cited by 8
Clinical considerations for critically ill COVID-19 cancer patients: A systematic review
Ramasamy, C., Mishra, A. K., John, K., & Lal, A. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i28.8441 · Cited by 8
COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study
Wang, X. A., Binder, A. F., Gergis, U. S., & Wilde, L. R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.740320 · Cited by 8
Overheu, O., Quast, D. R., Schmidt, W. E., Sakιnç, T., & Reinacher‐Schick, A. (2021) · Oncology Research and Treatment · doi:10.1159/000520572 · Cited by 8
Acquati, C., Chen, T. A., Leal, I. M., Connors, S. K., Haq, A. A., Rogova, A., Ramirez, S., Reitzel, L. R., & McNeill, L. H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182413084 · Cited by 9
Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients
Lak, E., Mohammadi, M. J., & Yousefi, H. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.12.004 · Cited by 8
Mercolini, F., & Cesaro, S. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.009 · Cited by 9
Gastrointestinal Manifestations in Patients Infected with SARS-CoV-2
Arefinia, N., Ghoreshi, Z., Alipour, A. H., Mollaei, H. R., Samie, M., & Sarvari, J. (2022) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.16.4.271 · Cited by 8
Sherratt, F. C., Fisher, P., Mathieson, A., Cherry, M. G., Pettitt, A. R., & Young, B. (2022) · Trials · doi:10.1186/s13063-022-06453-z · Cited by 8
Sharma, M., Kumar, R., & Chauhan, P. (2022) · Journal of Global Operations and Strategic Sourcing · doi:10.1108/jgoss-03-2022-0017 · Cited by 10
Meng, M., Gao, R., Liu, Z., Liu, F., Du, S., Song, Y., & He, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1085509 · Cited by 8
Karataş, T., Ayaz‐Alkaya, S., & Özdemir, N. (2023) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2023.151420 · Cited by 12
Revitalising cancer trials post-pandemic: time for reform
Morton, C., Sullivan, R. J., Sarker, D., Posner, J., & Spicer, J. F. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02224-y · Cited by 8
Addabbo, F., Giotta, M., Mincuzzi, A., Minerba, A. S., Prato, R., Fortunato, F., Bartolomeo, N., & Trerotoli, P. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20085522 · Cited by 8
Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d’Or, France
Agbo, C. F., Assogba, E., Bertaut, A., Kamga, A. M., Coutant, C., Desmoulins, I., Dancourt, V., & Dabakuyo‐Yonli, T. S. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102248 · Cited by 8
Lambert, P. J., Musto, G., Thiessen, M. H., Czaykowski, P., & Decker, K. (2023) · Current Oncology · doi:10.3390/curroncol30070446 · Cited by 10
Immunodiagnosis — the promise of personalized immunotherapy
Wang, R., Xiong, K., Wang, Z., Wu, D., Hu, B., Ruan, J., Sun, C., Ma, D., Li, L., & Liao, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1216901 · Cited by 9
Melano, I., Cheng, W., Kuo, L.-L., Liu, Y.-M., Chou, Y., Hung, M., Lai, M. M. C., Sher, Y., & Su, W. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03854-22 · Cited by 8
Self-citationRukasha, I., Lekalakala-Mokaba, M. R., Satekge, T. M., & Kaapu, K. G. (2023) · Motaleat-e Tatbiqi-e Honar · doi:10.61186/jommid.11.2.62 · Cited by 8
Baker, S. J. C., Nfonsam, L. E., Leto, D., Rutherford, C., Smieja, M., & McArthur, A. G. (2024) · Virology Journal · doi:10.1186/s12985-023-02278-7 · Cited by 9
Brown, J. M., Wasson, M. D., & Marcato, P. (2021) · Cancers · doi:10.3390/cancers13020296 · Cited by 9
Ehmsen, S., Jakobsen, L. H., Lendorf, M. E., Eefsen, R. L., Bentsen, L., Knoop, A. S., Pedersen, N. A., Skúladóttir, H., Herrstedt, J., Jensen, L. H., et al. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1889659 · Cited by 8
Ye, C., Qi, L., Ji, W., & Zheng, S. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.606755 · Cited by 8
Goudsmit, A., Cubilier, E., Meert, A., Aftimos, P. G., Stathopoulos, K., Spilleboudt, C., & Loizidou, A. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06175-z · Cited by 8
Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19
Klein, I. A., Rosenberg, S. M., Reynolds, K. L., Zubiri, L., Rosovsky, R. P. G., Piper‐Vallillo, A. J., Gao, X. Y., Boland, G. M., Bardia, A., Gaither, R., et al. (2021) · The Oncologist · doi:10.1002/onco.13794 · Cited by 8
Self-citationEscobar, V. D. F., Chorro, L. M., Orellana, R. B., Rodríguez, C. R., Urbina, O., & de Blanco, C. L. (2021) · ALERTA Revista Científica del Instituto Nacional de Salud · doi:10.5377/alerta.v4i2.10366 · Cited by 8
Mechanism and transmission routes of COVID-19
Kirubananthan, L., Illuri, R., Rajendran, R., & Chandrasekaran, P. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85780-2.00013-5 · Cited by 8
Lipe, D. N., Bourenane, S. S., Wattana, M. K., Gaeta, S., Chaftari, P. S., Carreras, M. T. C., Manzano, J.-G. M., & Reyes‐Gibby, C. C. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.02.002 · Cited by 8
Butkiewicz, S., Zaczyński, A., Hampel, M., Pańkowski, I., Gałązkowski, R., & Rzońca, P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19073932 · Cited by 8
Chen, M., Li, R., Ding, G., & Jin, C. (2022) · BioScience Trends · doi:10.5582/bst.2022.01251 · Cited by 8
Oliva, A., Curtolo, A., Volpicelli, L., Cancelli, F., Borrazzo, C., Dezza, F. C., Marcelli, G., Gavaruzzi, F., Bari, S. D., Ricci, P., et al. (2022) · Infection · doi:10.1007/s15010-022-01869-w · Cited by 8
COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment
Liapis, I., & Baritaki, S. (2022) · Cancers · doi:10.3390/cancers14174330 · Cited by 9
Zhang, Q., Liu, T., Ding, J., Zhou, N., Yu, Z., Ren, Y., Qin, X., Du, P., Yang, Z., & Zhu, H. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00541 · Cited by 8
Henig, I. J., Isenberg, J., Yehudai‐Ofir, D., Leiba, R., Ringelstein‐Harlev, S., Ram, R., Avni, B. R., Amit, O., Grisariu, S., Azoulay, T., et al. (2023) · Vaccines · doi:10.3390/vaccines11040775 · Cited by 7
Hanna, G. J., Rettig, E. M., Park, J. C., Varvares, M. A., Lorch, J. H., Margalit, D. N., Schoenfeld, J. D., Tishler, R. B., Goguen, L. A., Annino, D. J., et al. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.105087 · Cited by 9
Challenges Encountered in Cancer Care and Management During Covid-19 in South Asian Countries
Yadav, S. S., Zain, M., Sahai, P., Porwal, S., & Chauhan, V. (2020) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2020.5.s1.101-107 · Cited by 8
COVID-19 After Lung Resection in Northern Italy
Scarci, M., Raveglia, F., Bortolotti, L., Benvenuti, M. R., Merlo, L., Petrella, L., Cardillo, G., & Rocco, G. (2021) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2021.03.038 · Cited by 8
Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study
Palaia, I., Caruso, G., di Donato, V., Vestri, A., Napoli, A., Perniola, G., Casinelli, M., Fegatelli, D. A., Campagna, R., Tomao, F., et al. (2021) · Vaccines · doi:10.3390/vaccines10010012 · Cited by 7
Pandemic Medicine: The Management of Advanced Melanoma During COVID-19
Patrinely, J. R., & Johnson, D. B. (2020) · Melanoma Management · doi:10.2217/mmt-2020-0012 · Cited by 8
Chen, Z., Zhang, C., Yin, J., Xin, X., Li, H., Wang, Y., Tsang, B. K., & Zhang, Q. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00784-2 · Cited by 7
Self-citationWhen Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
Taoufik, Y., de Herve, M.-G. D. G., Corgnac, S., Dürrbach, A., & Mami‐Chouaib, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692598 · Cited by 7
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer
Hathaway, C. A., Siegel, E. M., Gonzalez, B. D., Oswald, L. B., Peoples, A. R., Ulrich, C. M., Penedo, F. J., Tworoger, S. S., & Islam, J. Y. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.09.063 · Cited by 7
Pergolotti, M., Pisegna, J., Chien, L., Brintzenhofeszoc, K., Kaur, A., Battisti, N., Canin, B., Malone, M. V., Shahrokni, A., Plotkin, E., et al. (2023) · Journal of cancer survivorship · doi:10.1007/s11764-023-01356-7 · Cited by 7
Ciszewski, W. M., Woźniak, L. A., & Sobierajska, K. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119541 · Cited by 7
Wang, D., Deng, X., Li, S., & Sana, S. R. G. L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112912 · Cited by 7
Li, P., Li, L., Wang, S., Liu, Y., Zhou, L., & Xia, S. (2021) · Cancer Medicine · doi:10.1002/cam4.3754 · Cited by 7
Self-citationde Oliveira, L. C., Rosa, K. S. D. C., Borsatto, A. Z., de Oliveira, L. A. F., de Freitas, R., & Sampaio, S. G. D. S. M. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06149-1 · Cited by 7
Clinical Experiences of People With a Laryngectomy During the SARS COVID-19 Pandemic
Searl, J. P., Kearney, A., Genoa, K., & Doyle, P. C. (2021) · American Journal of Speech-Language Pathology · doi:10.1044/2021_ajslp-21-00117 · Cited by 7
COVID-19 infection in pediatric patients treated for cancer
Oz-Alcalay, L., Elitzur, S., Amitai, N., Toledano, H., Barzilai‐Birenboim, S., Avrahami, G., Gilad, G., Vardi, Y., Dvori, M., Izraeli, S., et al. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02068-7 · Cited by 6
Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemic
Fathi, M., Vakili, K. G., Jazi, K., Sadeghi, M. A., Hajiesmaeili, M., Mohamadkhani, A., Rezaei–Tavirani, M., & Tavasol, A. (2021) · Tumori Journal · doi:10.1177/03008916211063939 · Cited by 7
Akingboye, A. A., Mahmood, F., Amiruddin, N., Reay, M., Nightingale, P., & Ogunwobi, O. O. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053352 · Cited by 7
Computational studies to identify the common type‐I and type‐II inhibitors against the CDK8 enzyme
Ghosh, A. N., Manhas, A., & Jha, P. C. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30209 · Cited by 7
Jin, R., Lim, H. J., Hamilton, S. N., & Ingledew, P. (2022) · Journal of Cancer Education · doi:10.1007/s13187-022-02136-0 · Cited by 7
Metadata
- Authors
- Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., Yu, T., Wang, L., Wang, H., Liu, Y., Chen, Y., Mei, J., Gao, X., Li, Z., Gan, L., He, C., Li, Z., Shi, Y., Qi, Y., Yang, J., Tenen, D. G., Chai, L., Mucci, L. A., Santillana, M., & Cai, H.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Wuhan Union Hospital (CN)
- Central Hospital of Wuhan (CN)
- Huanggang Central Hospital (CN)
- Guangzhou Medical University (CN)
- Tongji Hospital (CN)
- 16Department of Radiology, Hubei Cancer Hospital, Wuhan, Hubei, China.
- Hubei Cancer Hospital (CN)
- Renmin Hospital of Wuhan University (CN)
- 19Department of Oncology, Wuhan Puren Hospital, Wuhan, Hubei, China.
- Xianning Central Hospital (CN)
- The Central Hospital of Xiao gan (CN)
- 22Department of Obstetrics and Gynecology, The People's Hospital of Huangmei, Huangmei, Hubei, China.
- Hubei University of Medicine (CN)
- Harvard University (US)
- Corresponding author
- Liu, Miao
- Santillana, Mauricio
- Cai, Hongbing
- ORCID
- Venue
- Cancer Discovery
- Published
- 2020-06-01
- Volume
- 10
- Issue
- 6
- Pages
- 783-791
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC7309152
- OpenAlex
- W3015599879
- Cited by
- 1,589
- References
- 27
- Citations by year
- 2026: 16 · 2025: 55 · 2024: 90 · 2023: 218 · 2022: 354 · 2021: 494 · 2020: 356
- FWCI
- 128.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Discovery (publishedVersion)
- SSRN Electronic Journal (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (8197103302/H16)
- Singapore Ministry of Health's National Medical Research Council (MOH-STaR18nov-0002)
- NIH NHLBI (P01HL095489)
- Xiu Research Fund
- Institutional Ethics Board of Zhongnan Hospital of Wuhan University (2020029)
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- COVID-19 pandemic, SARS-CoV-2, cancer patients, disease severity, hematologic malignancies, lung cancer, metastatic cancer, radiotherapy, infection susceptibility
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Disease Outbreaks, Female, Humans, Intensive Care Units, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Respiration, Artificial, Cohort Studies, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
